Ipsen Biopharmaceuticals, Inc. is committed to finding innovative treatments for patients in the oncology, endocrinology and neurology therapeutic areas. Ipsen is interested in particularly rare and debilitating diseases for which there have been few treatment options for patients.

Endocrinology:

  • Acromegaly
  • Conditions related to IGF-1 (insulin like growth factor) deficiency

Neurology:

  • Movement Disorders

Oncology:

  • Neuroendocrine Tumors (NETs)